TNF and tuberculosis: The hazard ratio (HR) of MDR-TB, adjusted for age, sex, comorbidities, and history of previous inhaled corticosteroid treatment, was 3.26 times higher in patients treated with anti-TNF agents than in those who were never exposed to anti-TNF agents (HR 3.26, 95% CI 1.69–6.28) (Figure 2).